Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash	$ 6,460	$ 1,538
Accounts receivable	21	15
Prepaid expenses, deposits, and other current assets	933	1,004
Total current assets	7,414	2,557
Fixed assets, net	79	77
Operating lease right-of-use assets	1,872	2,002
Equity method investment - at fair value	35,998	34,120
Other assets	56	56
Total assets	45,419	38,812
Current liabilities:
Accounts payable	983	678
Accrued expenses and other current liabilities	2,093	2,486
Operating lease liabilities, current portion	588	573
Senior Secured Convertible Notes - at fair value	0	11,100
Total current liabilities	3,664	14,837
Senior Secured Convertible Notes - at fair value	14,900	0
Operating lease liabilities, less current portion	1,522	1,675
Total liabilities	20,431	16,512
Commitments and contingencies (Note 7)
Stockholders’ Equity (Deficit):
Common stock, $0.001 par value. Authorized, 25,000,000 shares (Note 12); 6,269,384 and 927,934 shares outstanding as of March 31, 2026 and December 31, 2025, respectively	6	1
Additional paid-in capital	294,788	268,019
Accumulated deficit	(259,028)	(258,731)
Total PAVmed Stockholders’ Equity (Deficit)	39,523	33,967
Noncontrolling interests	(14,535)	(11,667)
Total Stockholders’ Equity (Deficit)	24,988	22,300
Total liabilities and stockholders’ equity	45,419	38,812
Series B Preferred Stock [Member]
Stockholders’ Equity (Deficit):
Preferred stock	3,757	3,665
Series C Preferred Stock [Member]
Stockholders’ Equity (Deficit):
Preferred stock	0	21,013
Rights Liability [Member]
Current liabilities:
Rights liability	$ 345	$ 0